Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) appears in 241 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 4,481,926 | 2,551,601 | 132.19% | $314,445,646.00 |
| Deep Track Capital, LP | 31 Mar, 2026 | 3,600,000 | 595,966 | 19.84% | $252,540,000.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,552,612 | -237,945 | -6.28% | $249,215,733.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 3,346,025 | 10,705 | 0.32% | $234,723,654.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 2,562,154 | 0 | 0.00% | $179,735,103.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,944,272 | -96,470 | -4.73% | $136,390,741.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,760,541 | 1,760,541 | 0.00% | $123,501,951.00 |
| JENNISON ASSOCIATES LLC | 31 Mar, 2026 | 1,712,124 | -517,945 | -23.23% | $120,105,500.00 |
| Assenagon Asset Management S.A. | 31 Mar, 2026 | 1,280,194 | 152,464 | 13.52% | $89,805,609.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 1,194,377 | 436,271 | 57.55% | $83,785,547.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,188,624 | 0 | 0.00% | $83,381,974.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,121,091 | 173,328 | 18.29% | $78,658,404.00 |
| State Street Corp | 31 Mar, 2026 | 978,212 | 49,153 | 5.29% | $68,621,572.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 926,125 | -246,302 | -21.01% | $64,967,669.00 |
| LORD, ABBETT & CO. LLC | 31 Mar, 2026 | 842,313 | -13,332 | -1.56% | $59,088.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 791,146 | 175,990 | 28.61% | $55,498,892.00 |
| Invesco Ltd. | 31 Mar, 2026 | 742,497 | -269,860 | -26.66% | $52,086,165.00 |
| FMR LLC | 31 Mar, 2026 | 733,334 | 86,220 | 13.32% | $51,443,395.00 |
| Frazier Life Sciences Management, L.P. | 31 Mar, 2026 | 728,644 | 0 | 0.00% | $51,114,377.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 564,579 | 447,575 | 382.53% | $39,605,217.00 |